CTCBIO Inc.

₩2,595As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:060590Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (12.47%)
Div yield —
ROE 9.54%
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.03
PE TTM 8.277
TSR TTM (49.61%)
Mkt cap ₩62.04B
ROIC 9.80%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,733
5.34%
126.52%
Hold 9|6|10|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
48.01
47.52
50.60
49.10
15.49%
7.70%
19.53%
14.23%
Revenue₩B
4.443
4.482
4.727
4.961
5.27%
6.69%
9.52%
14.12%
Peers (US$45.74M)
Cap (US$)
PE
44.91M
—
44.84M
19.97x
Capital
TTM
5Y
10Y
Leveragex
5.537
0.124
0.091
EBIT/Intx
17.11
1.563
1.354
Own earn%
26.40
(32.92)
(40.85)
Sh yield%
31.96
38.49
35.64
Owners
Insiders/Inst%
3.21
46.21
Short interest%
2.89
SBC / revenue%
2.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
30–36
$1 testx
0.0
Incr. ROIC%
23